C. Metzger

发表

Outcomes with drug‐eluting stents versus bare metal stents in acute ST‐elevation myocardial infarction: Results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group

B. Brodie, T. Stuckey, J. Hermiller, 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of high on‐aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug‐eluting stents

Peter L Duffy, G. Stone, T. Henry, 2018, American heart journal.

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Vascular Closure Device During Percutaneous EVAR and TEVAR Procedures

M. Dake, D. Wood, A. Lumsden, 2020, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

Stenting and Angioplasty with Protection in Patients at High‐Risk for Endarterectomy: SAPPHIRE Worldwide Registry First 2,001 Patients

M. Solis, Rasesh M. Shah, R. Dave, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.

Hong Wang, D. Scheinert, M. Jaff, 2015, Journal of the American College of Cardiology.

Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease

D. Scheinert, M. Jaff, P. Krishnan, 2015, Circulation.

Pivotal Study of a Next-Generation Balloon-Expandable Stent-Graft for Treatment of Iliac Occlusive Disease

J. Bismuth, J. Panneton, B. Gray, 2017, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug‐Eluting Stents (ADAPT‐DES) study

Peter L Duffy, G. Stone, T. Henry, 2019, American heart journal.

Impact of transfer for primary percutaneous coronary intervention on survival and clinical outcomes (from the HORIZONS-AMI Trial).

G. Stone, H. Suryapranata, R. Mehran, 2010, The American journal of cardiology.

Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease.

J. Carrozza, J. Breall, A. Fernández, 2005, Journal of the American College of Cardiology.

Twelve-Month Results of the Nitinol Astron Stent in Iliac Artery Lesions.

M. Jaff, M. Brodmann, K. Tan, 2016, Journal of vascular and interventional radiology : JVIR.

Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries

Hong Wang, D. Scheinert, M. Jaff, 2018, Circulation. Cardiovascular interventions.

Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries

Hong Wang, D. Scheinert, M. Jaff, 2018, Circulation. Cardiovascular interventions.

SUPERB final 3‐year outcomes using interwoven nitinol biomimetic supera stent

M. Jaff, J. Popma, A. Pershad, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study.

Peter L Duffy, G. Stone, T. Henry, 2016, The American journal of cardiology.

Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD Registry

M. Shishehbor, Subhash Banerjee, E. Brilakis, 2022, Journal of interventional cardiology.

utcomes and Complications With Off-Label Use f Drug-Eluting Stents esults From the STENT ( Strategic Transcatheter Evaluation of ew Therapies ) Group

T. Stuckey, Barbara Bradshaw, William E. Downey, 2008 .

Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial.

G. Stone, R. Mehran, M. Fahy, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Differences Between Patients With Intermittent Claudication and Critical Limb Ischemia Undergoing Endovascular Intervention: Insights From the Excellence in Peripheral Artery Disease Registry

M. Shishehbor, Subhash Banerjee, E. Brilakis, 2021, Circulation. Cardiovascular interventions.

Impact of bivalirudin and paclitaxel-eluting stents on outcomes in patients undergoing primary percutaneous coronary intervention of the left anterior descending artery.

G. Stone, C. Grines, D. Dudek, 2013, The American journal of cardiology.

Novel laser‐based catheter for peripheral atherectomy: 6‐month results from the Eximo Medical B‐Laser™ IDE study

M. Brodmann, A. Micari, J. Rundback, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy.

A. Kirtane, J. Carrozza, J. Breall, 2008, JACC. Cardiovascular interventions.

3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.

P. Teirstein, G. Stone, S. Ellis, 2017, Journal of the American College of Cardiology.

Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.

Peter L Duffy, B. Brodie, T. Stuckey, 2009, JACC. Cardiovascular interventions.

Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial

L. Mauri, M. Jaff, J. Popma, 2015, Circulation. Cardiovascular interventions.

Long-Term Follow-up of Subjects With Iliac Occlusive Disease Treated With the Viabahn VBX Balloon-Expandable Endoprosthesis.

A. Cavadino, R. Sakhuja, B. Gray, 2023, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.

Peter L Duffy, B. Brodie, J. Hermiller, 2007, Journal of the American College of Cardiology.

Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group.

Peter L Duffy, B. Brodie, T. Stuckey, 2008, JACC. Cardiovascular interventions.

An integer based risk score for predicting 30-day major adverse cardiac or cerebrovascular events after percutaneous coronary intervention with drug-eluting stents: results from a large prospective multicentre registry, the STENT Group.

Peter L Duffy, B. Brodie, J. Hermiller, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Response to Letter Regarding Article, "Drug-Eluting or Bare Metal Stents for the Treatment of Saphenous Vein Graft Disease:

Peter L Duffy, J. Hermiller, L. Joseph, 2011 .

Safety and efficacy of carotid stenting in the very elderly

M. Bacharach, C. White, G. Ansel, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study.

Peter L Duffy, G. Stone, T. Henry, 2016, The American journal of cardiology.

Experience and outcomes with carotid artery stenting: an analysis of the CHOICE study (Carotid Stenting for High Surgical-Risk Patients; Evaluating Outcomes Through the Collection of Clinical Evidence).

W. Gray, M. Shishehbor, E. Blackstone, 2014, JACC. Cardiovascular interventions.

Acute and 30-day safety and effectiveness evaluation of Eximo Medical's B-Laser™, a novel atherectomy device, in subjects affected with infrainguinal peripheral arterial disease: Results of the EX-PAD-03 trial.

M. Brodmann, A. Micari, J. Rundback, 2018, Cardiovascular Revascularization Medicine.

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device.

M. Dake, W. O’Neill, D. Wood, 2019, Circulation. Cardiovascular interventions.

Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease

P. Faries, M. Shishehbor, M. Jaff, 2017, Circulation.

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study

Peter L Duffy, G. Stone, T. Henry, 2013, The Lancet.

Stenting and Angioplasty with Protection in Patients at High‐Risk for Endarterectomy: SAPPHIRE Worldwide Registry First 2,001 Patients

M. Solis, R. Dave, T. Schreiber, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.

P. Teirstein, G. Stone, S. Ellis, 2017, Journal of the American College of Cardiology.

Experience and Outcomes With Carotid Artery Stenting An Analysis of the CHOICE Study (Carotid Stenting for High Surgical-Risk Patients; Evaluating Outcomes Through the Collection of Clinical Evidence)

W. Gray, M. Shishehbor, E. Blackstone, 2022 .

Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy.

A. Kirtane, J. Carrozza, J. Breall, 2008, JACC. Cardiovascular interventions.

Response by Schneider et al to Letter Regarding Article, "Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial".

Hong Wang, D. Scheinert, M. Jaff, 2018, Circulation. Cardiovascular interventions.